Patients were ineligible if they had experienced prolonged cardiac arrest (requiring advanced life support for more than five minutes before randomization), recently used Ang II (within 24 hours), or had documented hypersensitivity to Ang II. The gene discussed is AGT; the disease is cardiac arrest.